Cassava Sciences, Inc.

Contributing Author

Recent Articles by Cassava Sciences, Inc.

Oct-22	Cassava Sciences Appoints Dawn C. Bir to the Board of Directors SAVA GlobeNewswire
Aug-25	Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference SAVA GlobeNewswire
Aug-14	Cassava Reports Q2 2025 Financials Results and Provides Business Update SAVA GlobeNewswire
Aug-07	Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer SAVA GlobeNewswire
Aug-04	Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy SAVA GlobeNewswire
Jun-30	Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting SAVA GlobeNewswire
May-08	Cassava Reports Q1 2025 Financials Results, Provides Business Update SAVA GlobeNewswire